胆固醇摄入量和阿托瓦斯塔丁调节SCD1和ELOVL6在老鼠逆皮质脂肪组织中
Jagoda Drag1, Marek Szlosarczyk2, Anna Gawedzka1
1Department of Biochemical Analytics, Faculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland.
Fundamental & clinical pharmacology
|September 17, 2025
概括
富含胆固醇的饮食增加了醇-CoA脱酶1 (SCD1) 指数,减少了单不和脂肪酸 (MUFA) 合成的和脂肪 (SAT). 阿托瓦斯塔丁降低了MUFA,表明在高胆固醇贫血大鼠中具有保护作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 营养科学 营养科学
背景情况:
- 基CoA脱酶1 (SCD1) 和长酶6 (ELOVL6) 是单不和脂肪酸 (MUFA) 合成的关键酶.
- 它们的基因表达在白色脂肪组织 (WAT) 中显著高,并且通过转录调节.
研究的目的:
- 为了研究胆固醇丰富的饮食和阿托瓦斯塔丁对高胆固醇贫血大鼠逆皮血 (rWAT) 的SCD1和ELOVL6的影响.
- 评估mRNA和蛋白质水平的变化,以及酶指数.
主要方法:
- 定量实时PCR (RT-qPCR) 用于mRNA量化.
- 西方涂抹用于蛋白质水平的确定.
- 气相色谱用于脂肪酸成分分析和索引计算.
主要成果:
- 富含胆固醇的饮食导致和脂肪 (SAT) 减少,多不和脂肪酸 (PUFA) 增加.
- 阿托瓦斯塔丁治疗增加了SCD1mRNA和蛋白质水平,但降低了rWAT中的MUFA含量.
- 胆固醇丰富饮食改变了SCD1和脂肪酸延长指数.
结论:
- 富含胆固醇的饮食通过增加SCD1指数来促进MUFA合成,利用SAT.
- 阿托瓦斯塔丁通过降低MUFA含量,在高胆固醇贫血的老鼠rWAT中发挥保护作用.
- 虽然阿托瓦斯塔丁上调SCD1表达,但在这种情况下它不会改变SCD1指数.
相关概念视频
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Lipid Catabolism
862
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
862


